Humedix Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jin-hwan Kim

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	0.05%
Management average tenure	no data
Board average tenure	no data

Recent management updates

No updates

Recent updates

Humedix (KOSDAQ:200670) Has A Pretty Healthy Balance Sheet

Mar 09

Humedix Co., Ltd.'s (KOSDAQ:200670) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 16

Should You Buy Humedix Co., Ltd. (KOSDAQ:200670) For Its Dividend?

Jan 28

Are Humedix's (KOSDAQ:200670) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 11

What Type Of Returns Would Humedix's(KOSDAQ:200670) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 22

Here's Why Humedix (KOSDAQ:200670) Can Manage Its Debt Responsibly

Dec 01

CEO

Jin-hwan Kim (58 yo)

no data

Tenure

Jin-hwan Kim is Chief Executive Officer of Humedix Co., Ltd.

Humedix Management

Management criteria checks 0/4

Key information

Recent management updates

Recent updates

Price target increased by 17% to ₩56,000

Upcoming dividend of ₩275 per share

Price target decreased by 15% to ₩56,000

Consensus EPS estimates fall by 11%, revenue upgraded

Upcoming dividend of ₩400 per share

Humedix Co., Ltd. (KOSDAQ:A200670) announces an Equity Buyback for KRW 3,000 million worth of its shares.

An unknown buyer agreed to acquire a 22.3% stake in Huons Meditech from Humedix Co., Ltd. (KOSDAQ:A200670) for KRW 21.5 billion.

Now 21% undervalued after recent price drop

Now 23% undervalued after recent price drop

Upcoming dividend of ₩400 per share

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ₩330 (vs ₩99.00 in 1Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Humedix Co., Ltd. announced that it has received KRW 45 billion in funding from a group of investors

Full year 2020 earnings released: EPS ₩1,587 (vs ₩1,094 in FY 2019)

Humedix (KOSDAQ:200670) Has A Pretty Healthy Balance Sheet

New 90-day high: ₩26,050

Investor sentiment improved over the past week

Humedix Co., Ltd.'s (KOSDAQ:200670) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Should You Buy Humedix Co., Ltd. (KOSDAQ:200670) For Its Dividend?

New 90-day low: ₩21,250

Are Humedix's (KOSDAQ:200670) Statutory Earnings A Good Reflection Of Its Earnings Potential?

What Type Of Returns Would Humedix's(KOSDAQ:200670) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Upcoming Dividend of ₩400 Per Share

Here's Why Humedix (KOSDAQ:200670) Can Manage Its Debt Responsibly

New 90-day low: ₩23,500

New 90-day low: ₩24,050

New 90-day high - ₩29,250

New 90-day high - ₩29,100

CEO

Tenure